Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 251

1.

Capturing saccades in multiple sclerosis with a digitized test of rapid number naming.

Hainline C, Rizzo JR, Hudson TE, Dai W, Birkemeier J, Raynowska J, Nolan RC, Hasanaj L, Selesnick I, Frohman TC, Frohman EM, Galetta SL, Balcer LJ, Rucker JC.

J Neurol. 2017 May;264(5):989-998. doi: 10.1007/s00415-017-8484-1. Epub 2017 Apr 7.

PMID:
28389741
2.

Impaired sweating responses to a passive whole-body heat stress in individuals with multiple sclerosis.

Allen DR, Huang M, Parupia IM, Dubelko AR, Frohman EM, Davis SL.

J Neurophysiol. 2017 Mar 8:jn.00897.2016. doi: 10.1152/jn.00897.2016. [Epub ahead of print]

PMID:
28275061
3.

Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.

Meltzer E, Sguigna PV, Subei A, Beh S, Kildebeck E, Conger D, Conger A, Lucero M, Frohman BS, Frohman AN, Saidha S, Galetta S, Calabresi PA, Rennaker R, Frohman TC, Kardon RH, Balcer LJ, Frohman EM.

JAMA Neurol. 2017 May 1;74(5):574-582. doi: 10.1001/jamaneurol.2016.5131.

PMID:
28135360
4.

Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.

Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, Balcer LJ, Frohman EM, Prince J, Calabresi PA, Saidha S.

Neurology. 2017 Feb 7;88(6):525-532. doi: 10.1212/WNL.0000000000003582. Epub 2017 Jan 11.

PMID:
28077493
5.

High-dose methotrexate with leucovorin rescue: For monumentally severe CNS inflammatory syndromes.

Beh SC, Kildebeck E, Narayan R, Desena A, Schell D, Rowe ES, Rowe V, Burns D, Whitworth L, Frohman TC, Greenberg B, Frohman EM.

J Neurol Sci. 2017 Jan 15;372:187-195. doi: 10.1016/j.jns.2016.11.012. Epub 2016 Nov 15.

PMID:
28017209
6.

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators..

N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.

PMID:
28002688
7.

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators..

N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21.

PMID:
28002679
8.

Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.

Hubbard NA, Turner M, Hutchison JL, Ouyang A, Strain J, Oasay L, Sundaram S, Davis S, Remington G, Brigante R, Huang H, Hart J Jr, Frohman T, Frohman E, Biswal BB, Rypma B.

J Cereb Blood Flow Metab. 2016 Nov;36(11):1872-1884. Epub 2015 Nov 9.

PMID:
26661225
9.

CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.

Chen D, Ireland SJ, Remington G, Alvarez E, Racke MK, Greenberg B, Frohman EM, Monson NL.

J Immunol. 2016 Dec 1;197(11):4257-4265. Epub 2016 Oct 26.

10.

The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson.

Kildebeck EJ, Narayan R, Nath A, Weiner H, Beh S, Calabresi PA, Steinman L, Major EO, Frohman TC, Frohman EM.

J Neurol. 2017 Apr;264(4):817-828. doi: 10.1007/s00415-016-8293-y. Epub 2016 Oct 12. No abstract available.

PMID:
27734166
11.

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.

Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators..

Neurology. 2016 Nov 8;87(19):1985-1992. Epub 2016 Oct 12.

12.

Cerebellar Control of Eye Movements.

Beh SC, Frohman TC, Frohman EM.

J Neuroophthalmol. 2017 Mar;37(1):87-98. doi: 10.1097/WNO.0000000000000456.

PMID:
27643747
13.

20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?

Sabadia SB, Nolan RC, Galetta KM, Narayana KM, Wilson JA, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2016 Dec;36(4):369-376.

PMID:
27472185
14.

Neurotherapeutic Strategies for Multiple Sclerosis.

Frohman TC, Beh SC, Kildebeck EJ, Narayan R, Treadaway K, Greenberg B, Frohman EM.

Neurol Clin. 2016 Aug;34(3):483-523. doi: 10.1016/j.ncl.2016.05.001. Review.

PMID:
27445239
15.

Characterizing retinal structure injury in African-Americans with multiple sclerosis.

Seraji-Bozorgzad N, Reed S, Bao F, Santiago C, Tselis A, Bernitsas E, Caon C, Frohman E, Bhatti MT, Cree BA, Khan O.

Mult Scler Relat Disord. 2016 May;7:16-20. doi: 10.1016/j.msard.2016.02.009. Epub 2016 Feb 12.

PMID:
27237751
16.

Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.

Mohiuddin IH, Pillai V, Baughman EJ, Greenberg BM, Frohman EM, Crawford MP, Sinha S, Karandikar NJ.

Clin Immunol. 2016 May;166-167:12-8. doi: 10.1016/j.clim.2016.05.001. Epub 2016 May 3.

17.

Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.

Dubey D, Zhang Y, Graves D, DeSena AD, Frohman E, Greenberg B.

Ther Adv Neurol Disord. 2016 May;9(3):211-5. doi: 10.1177/1756285615621029. Epub 2015 Dec 17. Review.

18.

In memoriam: The legacies of John F. Kurtzke and Richard T. Johnson.

Kildebeck EJ, Frohman EM.

Nat Rev Neurol. 2016 May;12(5):256-7. doi: 10.1038/nrneurol.2016.47. Epub 2016 Apr 15. No abstract available.

PMID:
27080520
19.

Impaired carotid baroreflex control of arterial blood pressure in multiple sclerosis.

Huang M, Allen DR, Keller DM, Fadel PJ, Frohman EM, Davis SL.

J Neurophysiol. 2016 Jul 1;116(1):81-7. doi: 10.1152/jn.00003.2016. Epub 2016 Apr 13.

PMID:
27075533
20.

In Memoriam: John F. Kurtzke, MD (1926-2015): A Founding Father of Neuroepidemiology and Pioneer of Modern Clinical Trial Design.

Frohman EM, Stüve O, Frohman TC, Lisak R.

JAMA Neurol. 2016 Apr;73(4):482-3. doi: 10.1001/jamaneurol.2016.0030. No abstract available.

PMID:
27064556

Supplemental Content

Loading ...
Support Center